IRDVSPRME• 7 Days (Normalized)
IRD vs PRME (Opus Genetics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Sep, 07 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
IRD Performance $5.97
+37.56%
Opus Genetics Inc.
Normalized Baseline0.00%
PRME Performance $3.18
-10.67%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin IRD LEADS
+48.23%
IRD outperforming by 48.23%
IRDPRME
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
IRD PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | IRD Price | IRD Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $5.97 | +37.56% | $3.18 | -10.67% | +48.23% |
| Sep 11, 2026 | $6.04 | +39.17% | $3.13 | -12.08% | +51.25% |
| Sep 10, 2026 | $6.07 | +39.86% | $3.35 | -5.90% | +45.76% |
| Sep 09, 2026 | $5.73 | +32.03% | $3.47 | -2.53% | +34.56% |
| Sep 08, 2026 | $4.34 | +0.00% | $3.56 | +0.00% | +0.00% |